General description

FTA Elute Cards utilize patented Whatman FTA technology that simplifies the handling and processing of nucleic acids. DNA is eluted in an easy step, providing you with DNA in solution for your amplification needs.The FTA Elute matrix is chemically treated with proprietary reagents that lyse cells upon contact causing the release of nucleic acids. DNA is recovered from the FTA Elute matrix through a simplified elution process using water and heat. Inhibitory components, such as hemoglobin, are retained on the FTA Elute matrix.• Samples can be collected, shipped, and stored at room temperature: Eliminates high costs associated with shipping samples on ice and with laboratory freezer storage requirements. • Sample processing time to isolate DNA is 15 to 30 min: Eliminates lengthy and multiple step isolation procedure (4 to 16 h). • Sample processing requires a simple hot water elution procedure to isolate DNA: Eliminates cost of using a purification kit. • Sample volume requirements are minimal: 12 to 40 µl per collection area. Eliminates venous blood samples and large blood volume handling/processing. Eliminates the need for venipuncture equipment and a medical attendant at the site of collection. • Hemoglobin, a known PCR inhibitor, is bound to the FTA Elute matrix: DNA is recovered in solution free of PCR inhibitors. The Indicating FTA Elute matrix is the same chemistry as FTA Elute with an indicating dye that changes from purple to white upon application of a colorless sample such as saliva, urine, buccal cell swabs, cultured cells, and bacterial cultures.

Legal Information

FTA is a registered trademark of GE Healthcare

Whatman is a registered trademark of GE Healthcare

Other Notes

Field of Use : The processing of genetic material whereby a solid matrix is utilized for the isolation, storage, purification or processing.